Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 2,149 | 2,954 | 421 | 1,576 | 3,336 |
| Gross Profit | 2,149 | 2,954 | 421 | 1,576 | 3,336 |
| Operating Expenses | 9,744 | 11,589 | 12,720 | 11,210 | 12,151 |
| Operating Income | -7,595 | -8,635 | -12,299 | -9,634 | -8,815 |
| Interest Expense | 75 | 45 | 128 | 152 | 188 |
| Other Income | 222 | 198 | 170 | 290 | 343 |
| Pre-tax Income | -7,448 | -8,482 | -12,257 | -9,496 | -8,660 |
| Net Income Continuous | -7,448 | -8,482 | -12,257 | -9,496 | -8,660 |
| Net Income | $-7,448 | $-8,482 | $-12,257 | $-9,496 | $-8,660 |
| EPS Basic Total Ops | -0.07 | -0.09 | -0.17 | -0.10 | -0.17 |
| EPS Basic Continuous Ops | -0.07 | -0.09 | -0.17 | -0.10 | -0.17 |
| EPS Diluted Total Ops | -0.07 | -0.09 | -0.17 | -0.10 | -0.17 |
| EPS Diluted Continuous Ops | -0.07 | -0.09 | -0.17 | -0.10 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.09 | -0.17 | -0.13 | -0.17 |
| EBITDA(a) | $-7,687 | $-8,527 | $-12,189 | $-9,527 | $-8,704 |